Being PrEPared Despite its proven benefits, preexposure prophylaxis against HIV (PrEP) has been prescribed to only a fraction of the population that would benefit from it. Stigma and limited awareness are substantial barriers to improving uptake in the communities at the highest risk.
No takes yet. Share an insight, caveat, or question.
Goldstein et al. (2018) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: